Divan raised the price target on Johnson & Johnson stock.

1 report, 1 independent Updated Jun 26

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

DivanJohnson & Johnson

Keep exploring

Part of

MarketScreener reports on analyst ratings and price targets for Johnson & Johnson. All 1 developments

The entities involved

Johnson & Johnson
U.S multinational medical devices, pharmaceutical and consumer packaged goods manufacturer
- P&G, Johnson & Johnson, and Coca-Cola are noted as dividend growth stocks, coinciding with SEC requirements for fiduciaries to prioritize interests.Mon 00:50
- Johnson & Johnson separated its Consumer Health business into Kenvue on August 25, 2025.Sun 04:04

Coverage

Newest first; wire copies grouped

Jun 26fool.com